| Title : SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial - Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125 |
| Author(s) : Inagaki N , Onouchi H , Sano H , Funao N , Kuroda S , Kaku K |
| Ref : Lancet Diabetes Endocrinol , 2 :125 , 2014 |
| Abstract : Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125 |
| ESTHER : Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125 |
| PubMedSearch : Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125 |
| PubMedID: 24622716 |
Inagaki N, Onouchi H, Sano H, Funao N, Kuroda S, Kaku K (2014)
SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial
Lancet Diabetes Endocrinol
2 :125
Inagaki N, Onouchi H, Sano H, Funao N, Kuroda S, Kaku K (2014)
Lancet Diabetes Endocrinol
2 :125